Citigroup’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121K | Buy |
12,143
+11,652
| +2,373% | +$116K | ﹤0.01% | 3596 |
|
|
2025
Q1 | $43.1K | Buy |
491
+28
| +6% | +$2.46K | ﹤0.01% | 4147 |
|
|
2024
Q4 | $43K | Sell |
463
-6,206
| -93% | -$576K | ﹤0.01% | 4279 |
|
|
2024
Q3 | $488K | Buy |
6,669
+6,568
| +6,503% | +$480K | ﹤0.01% | 3002 |
|
|
2024
Q2 | $5.89K | Buy |
101
+28
| +38% | +$1.63K | ﹤0.01% | 4482 |
|
|
2024
Q1 | $75.3K | Buy |
73
+13
| +22% | +$13.4K | ﹤0.01% | 3681 |
|
|
2023
Q4 | $47.4K | Buy |
60
+54
| +900% | +$42.7K | ﹤0.01% | 3804 |
|
|
2023
Q3 | $2.89K | Sell |
6
-89
| -94% | -$42.9K | ﹤0.01% | 4119 |
|
|
2023
Q2 | $57K | Buy |
95
+88
| +1,257% | +$52.8K | ﹤0.01% | 3893 |
|
|
2023
Q1 | $4.62K | Sell |
7
-3
| -30% | -$1.98K | ﹤0.01% | 4267 |
|
|
2022
Q4 | $10.2K | Sell |
10
-5
| -33% | -$5.11K | ﹤0.01% | 4124 |
|
|
2022
Q3 | $8K | Sell |
15
-16
| -52% | -$8.53K | ﹤0.01% | 4302 |
|
|
2022
Q2 | $17K | Sell |
31
-10
| -24% | -$5.48K | ﹤0.01% | 4388 |
|
|
2022
Q1 | $26K | Sell |
41
-58
| -59% | -$36.8K | ﹤0.01% | 4287 |
|
|
2021
Q4 | $41K | Buy |
99
+66
| +200% | +$27.3K | ﹤0.01% | 4390 |
|
|
2021
Q3 | $24K | Buy |
+33
| New | +$24K | ﹤0.01% | 4397 |
|